Maurice J. Cairoli, MD
Board Certifications: Internal Medicine and Medical Oncology
Languages: English
Locations: Moorestown, NJ
Dr. Cairoli, who practices in New Jersey in Moorestown, has treated patients in this southern New Jersey community for more than 25 years. His special interest is in Breast Cancer, and he is a member of the Breast Cancer Committee at Virtua Memorial Hospital. After graduating from Notre Dame, he obtained his medical degree from New York Medical College followed by his fellowship at Barnes Hospital (Washington School of Medicine) in Hematology/Oncology.
Education
Medical Education
University of Notre Dame, bachelor’s degree, New York Medical College medical degree
Residency
Barnes Hospital/Washington University School of Medicine, residency in internal medicine
fellowship
Barnes Hospital/Washington University School of Medicine, fellowship in hematology and oncology
Awards and honors
Awards and honors
- Jersey’s Best Magazine Top Doctors: 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Jersey’s Best – Top Doctors for Women’s Health: 2015, 2016, 2017, 2018, 2021, 2022, 2023, 2024
- Jersey’s Best – Top Doctors for Cancer: 2015, 2016, 2017, 2018, 2019, 2021, 2022, 2023, 2024
- Philadelphia Magazine: 2018, 2019, 2020, 2021, 2022, 2023
- Philadelphia Magazine: Cancer Doctors: 2020
- South Jersey Magazine’s Top Physicians for Women: 2022
- South Jersey Magazine’s Top Doctor: 2022
Professional Memberships
American College of Physicians, American Society of Clinical Oncology, New Jersey State Oncology Society, Medical Society of New Jersey
Hospital Affiliations
Virtua Memorial Hospital
we are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.